Treace Medical Concepts (TMCI) Change in Accured Expenses (2020 - 2026)

Treace Medical Concepts has reported Change in Accured Expenses for 7 years, with the latest figure at -$3.1 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Accured Expenses rose 49.3% year-over-year to -$3.1 million; the trailing twelve-month figure through Mar 2026 stood at $627000.0 (up 108.77% YoY), and the FY2025 full-year result was -$2.4 million, up 69.47% from the prior year.
• Change in Accured Expenses for Q1 2026 stood at -$3.1 million, down from $778000.0 in the prior quarter.
• The five-year high for Change in Accured Expenses was $9.5 million in Q4 2023, with the low at -$6.9 million in Q1 2024.
• Historically, Change in Accured Expenses has averaged $71235.3 across 5 years, with a median of $939000.0 in 2023.
• Annual changes were most pronounced in 2022 — Change in Accured Expenses surged 192.95% — and 2024, when it plunged 675.66%.
• Treace Medical Concepts' Change in Accured Expenses stood at $6.9 million in 2022, then soared by 37.36% to $9.5 million in 2023, then sank by 48.85% to $4.8 million in 2024, then sank by 83.96% to $778000.0 in 2025, then slumped by 501.8% to -$3.1 million in 2026.
• The last three Change in Accured Expenses figures came in at -$3.1 million (Q1 2026), $778000.0 (Q4 2025), and $2.1 million (Q3 2025), per Business Quant data.